JP2016508026A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016508026A5 JP2016508026A5 JP2015542310A JP2015542310A JP2016508026A5 JP 2016508026 A5 JP2016508026 A5 JP 2016508026A5 JP 2015542310 A JP2015542310 A JP 2015542310A JP 2015542310 A JP2015542310 A JP 2015542310A JP 2016508026 A5 JP2016508026 A5 JP 2016508026A5
- Authority
- JP
- Japan
- Prior art keywords
- pca
- category
- composite value
- biomarker
- snppc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1251310 | 2012-11-20 | ||
| SE1251310-7 | 2012-11-20 | ||
| SE1350602-7 | 2013-05-16 | ||
| SE1350602 | 2013-05-16 | ||
| PCT/EP2013/074270 WO2014079874A1 (en) | 2012-11-20 | 2013-11-20 | Prognostic method for individuals with prostate cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016508026A JP2016508026A (ja) | 2016-03-17 |
| JP2016508026A5 true JP2016508026A5 (enExample) | 2017-01-05 |
Family
ID=49713059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015542310A Pending JP2016508026A (ja) | 2012-11-20 | 2013-11-20 | 前立腺癌を有する個体の予後診断方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10428385B2 (enExample) |
| EP (1) | EP2922970B1 (enExample) |
| JP (1) | JP2016508026A (enExample) |
| AU (1) | AU2013349721B2 (enExample) |
| CA (1) | CA2891394C (enExample) |
| ES (1) | ES2694409T3 (enExample) |
| RU (1) | RU2669809C2 (enExample) |
| WO (1) | WO2014079874A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108108590A (zh) | 2012-03-05 | 2018-06-01 | 阿克蒂克合伙公司 | 分析系统和方法 |
| DK2922967T3 (en) | 2012-11-20 | 2018-04-16 | Phadia Ab | PROCEDURE FOR VIEWING A PRESENCE OR NON-PRESENCE OF AGGRESSIVE PROSTATANCES |
| AU2015230017B2 (en) * | 2014-03-11 | 2021-06-17 | A3P Biomedical Ab | Method for detecting a solid tumor cancer |
| MX392384B (es) | 2014-03-28 | 2025-03-24 | Opko Diagnostics Llc | Composiciones y metodos relacionados con el diagnostico de cancer de prostata. |
| US12326453B2 (en) | 2014-03-28 | 2025-06-10 | Opko Diagnostics, Llc | Compositions and methods for active surveillance of prostate cancer |
| EP3253800B1 (en) | 2015-03-27 | 2021-03-03 | Opko Diagnostics, LLC | Prostate antigen standards and uses thereof |
| HK1247824A1 (zh) * | 2015-04-29 | 2018-10-05 | 欧普科诊断有限责任公司 | 用於主动监控前列腺癌的组合物和方法 |
| JP6570929B2 (ja) * | 2015-09-08 | 2019-09-04 | 国立研究開発法人農業・食品産業技術総合研究機構 | 特性推定モデル生成装置および方法、解析対象の特性推定装置および方法 |
| US20190345565A1 (en) * | 2017-02-01 | 2019-11-14 | Phadia Ab | Method for indicating a presence or non-presence of prostate cancer in individuals with particular characteristics |
| WO2019144112A1 (en) * | 2018-01-22 | 2019-07-25 | Phadia Ab | Method for the harmonization of assay results |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| BRPI0807236A2 (pt) | 2007-02-07 | 2019-09-24 | Decode Genetics Ehf | métodos para determinar uma suscetibilidade para câncer de próstata em um indivíduo humano, para identificar um marcador para uso em avaliação de suscetibilidade para câncer de próstata e para genotipificar uma amostra de ácido nucleico obtida de um indivíduo humano sob risco de, ou diagnosticado com, câncer de prostáta, para avaliar um indivíduo humano para probabiliade da resposta a um agente terapêutico para prevenir e/ou melhorar sintomas associados com câncer de próstata, para predizer prognóstico de um indivíduo diagnosticado com câncer e para monitorar progresso de um tratamento de um indivíduo sofrendo tratamento para câncer de próstata, kit para avaliar suscetibilidade para câncer de próstata em um indivíduo humano, uso de uma sonda de oligonucleotídeo, meio legível por computador, e , aparelho para determinar um indicador genético para câncer de próstata em um indivíduo humano. |
| US9732389B2 (en) | 2010-09-03 | 2017-08-15 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| US20120202888A1 (en) | 2010-10-08 | 2012-08-09 | The Brigham And Women's Hospital, Inc. | Biomarkers of prostate cancer and predicting mortality |
| US20120150032A1 (en) * | 2010-12-13 | 2012-06-14 | Julius Gudmundsson | Sequence Variants Associated with Prostate Specific Antigen Levels |
| CA2871877A1 (en) | 2012-05-16 | 2013-11-21 | Phadia Ab | Method for indicating the presence or non-presence of prostate cancer |
| DK2922967T3 (en) | 2012-11-20 | 2018-04-16 | Phadia Ab | PROCEDURE FOR VIEWING A PRESENCE OR NON-PRESENCE OF AGGRESSIVE PROSTATANCES |
-
2013
- 2013-11-20 CA CA2891394A patent/CA2891394C/en active Active
- 2013-11-20 ES ES13799501.5T patent/ES2694409T3/es active Active
- 2013-11-20 AU AU2013349721A patent/AU2013349721B2/en active Active
- 2013-11-20 WO PCT/EP2013/074270 patent/WO2014079874A1/en not_active Ceased
- 2013-11-20 EP EP13799501.5A patent/EP2922970B1/en active Active
- 2013-11-20 US US14/443,974 patent/US10428385B2/en active Active
- 2013-11-20 JP JP2015542310A patent/JP2016508026A/ja active Pending
- 2013-11-20 RU RU2015124008A patent/RU2669809C2/ru active
-
2019
- 2019-09-19 US US16/575,940 patent/US20200010912A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016503301A5 (enExample) | ||
| AU2021232712B2 (en) | Method for detecting a solid tumor cancer | |
| Takeuchi et al. | The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer | |
| Okamura et al. | Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma | |
| Aly et al. | Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study | |
| Prensner et al. | RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1 | |
| Bonne et al. | Salivary biomarker development using genomic, proteomic and metabolomic approaches | |
| JP2019049559A (ja) | 侵攻性前立腺癌の存在または不存在を判定する方法 | |
| Martuszewski et al. | Donor-derived cell-free DNA in kidney transplantation as a potential rejection biomarker: a systematic literature review | |
| Wang et al. | Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma | |
| JP2017508970A5 (enExample) | ||
| JP2015524052A (ja) | 前立腺癌の存在または不存在の提示方法 | |
| ES2694409T3 (es) | Método de pronóstico para individuos con cáncer de próstata | |
| Irvine et al. | Multiplex serum protein analysis identifies novel biomarkers of advanced fibrosis in patients with chronic liver disease with the potential to improve diagnostic accuracy of established biomarkers | |
| Zhou et al. | Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection | |
| CN107657149B (zh) | 用于预测肝癌患者预后的系统 | |
| JP2016526167A5 (enExample) | ||
| Wu et al. | The prediction of epidermal growth factor receptor mutation and prognosis of EGFR tyrosine kinase inhibitor by serum ferritin in advanced NSCLC | |
| Yasuda et al. | Preoperative predictors of very early recurrence in patients with hepatocellular carcinoma beyond the Milan criteria | |
| Liang et al. | Prospective evaluation of operating characteristics of prostate cancer detection biomarkers | |
| FI3577237T3 (fi) | Menetelmä eturauhassyövän läsnäolon tai puuttumisen osoittamiseksi henkilöillä, joilla on tiettyjä ominaisuuksia | |
| Yang et al. | Gustative Roussy Immune Score is a Predictor for Major Pathological Response in Rectal Cancer: A Result from the Preoperative Intraarterial Chemoembolization Combined with Radiotherapy (PCAR) Study | |
| US20250210192A1 (en) | Methods for disease detection | |
| Hu et al. | Development of a redox-related prognostic signature for predicting biochemical-recurrence-free survival of prostate cancer | |
| Marconi et al. | Post partial nephrectomy surveillance imaging: an evidence-based approach |